Patents by Inventor Aimee L. Edinger

Aimee L. Edinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240066006
    Abstract: Antiviral compounds can be utilized to mitigate viral activity of enveloped viruses in an infected host. In some instances, a virally infected biological cell is contacted with an antiviral to mitigate viral activity in the biological cell. In some instances, a virally infected animal is administered an antiviral to mitigate viral activity in the animal. In some instances, an animal is prophylactically administered an antiviral to mitigate viral activity in the animal. Therapeutics and treatments involving antiviral compounds are also described.
    Type: Application
    Filed: December 17, 2021
    Publication date: February 29, 2024
    Applicant: The Regents of the University of California
    Inventors: Aimee L. Edinger, Brendan T. Finicle
  • Publication number: 20230122855
    Abstract: Small molecules comprised of azacyclic constrained sphingolipid-like compounds and methods of their synthesis are provided. Formulations and medicaments are also provided that are directed to the treatment of disease, such as, for example, neoplasms, cancers, and other diseases. Therapeutics are also provided containing a therapeutically effective dose of one or more small molecule compounds, present either as pharmaceutically effective salt or in pure form, including, but not limited to, formulations for oral, intravenous, or intramuscular administration.
    Type: Application
    Filed: October 13, 2022
    Publication date: April 20, 2023
    Applicants: The Regents of the University of California, The Université de Montréal
    Inventors: Aimee L. Edinger, Stephen Hanessian
  • Patent number: 11479530
    Abstract: Small molecules comprised of azacyclic constrained sphingolipid-like compounds and methods of their synthesis are provided. Formulations and medicaments are also provided that are directed to the treatment of disease, such as, for example, neoplasms, cancers, and other diseases. Therapeutics are also provided containing a therapeutically effective dose of one or more small molecule compounds, present either as pharmaceutically effective salt or in pure form, including, but not limited to, formulations for oral, intravenous, or intramuscular administration.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: October 25, 2022
    Assignees: The Regents of the University of California, The Université de Montréal
    Inventors: Aimee L. Edinger, Stephen Hanessian
  • Publication number: 20210261504
    Abstract: Small molecules comprised of azacyclic constrained sphingolipid-like compounds and methods of their synthesis are provided. Formulations and medicaments are also provided that are directed to the treatment of disease, such as, for example, neoplasms, cancers, and other diseases. Therapeutics are also provided containing a therapeutically effective dose of one or more small molecule compounds, present either as pharmaceutically effective salt or in pure form, including, but not limited to, formulations for oral, intravenous, or intramuscular administration.
    Type: Application
    Filed: March 8, 2021
    Publication date: August 26, 2021
    Applicants: The Regents of the University of California, The Université de Montréal
    Inventors: Aimee L. Edinger, Stephen Hanessian